To date, DNDi has developed 6 new treatments for neglected patients that are available in the field:

• ASAQ to treat malaria, launched in 2007

• ASMQ to treat malaria, launched in 2008

• NECT to treat late-stage sleeping sickness (human African trypanosomiasis), launched in 2009

• SSG&PM to treat visceral leishmaniasis (kala azar) in Africa, launched in 2010

• A set of combination therapies to treat visceral leishmaniasis (kala azar) in Asia, launched in 2011

• Pediatric dosage form of benznidazole to treat Chagas disease in children, launched in 2011